BORDONARO, ROBERTO
BORDONARO, ROBERTO
5-Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) plus Bevacizumab in patients with metastatic colo-rectal cancer (MCRC): a multicentric phase II trial
2009-01-01 Cordio, S; Soto Parra, Hj; Pumo, V; Condorelli, S; Latteri, F.; Sambataro, D; Rosati, G.; Aprile, G; Fassari, G; De Pauli, F; Bordonaro, R
A data collection representative of an outcome analysis in advanced Non Small Cell Lung Cancer (NSCLC) expressing EGFR mutations after failure of first line therapy with Tyrosine Kinase Inhibitors (TKIs) with careful on post progression survival
2016-01-01 Sergi, C.; Commendatore, O.; Burrafato, G.; Martines, C.; Garozzo, S.; Cordio, S.; Sambataro, D.; Cinà, D.; Miraponte, S.; Bordonaro, R.
Activity and safety of CPBev regimen (Cis-platinum, Pemetrexed and Bevacizumab) as first-line therapy for locally advanced or metastatic adenocarcinoma of the lung: final results of a phase II study.
2013-01-01 Bordonaro, Roberto; Soto-Parra, Hector; Sergi, Concetta; Giannitto Giorgio, Carmelo; Cinieri, Saverio; Latteri, Fiorenza; Cordio, Stefano; Salice, Placida; Morales, Concetta; Sambataro, Daniela; Potenza, Enrico
Activity and safety of CPBev regimen (cisplatinum, pemetrexed, and bevacizumab) as first-line therapy for locally advanced or metastatic adenocarcinoma of the lung: Final results of a phase II study.
2012-01-01 Bordonaro, Roberto; Soto-parra, Hector; Giannitto-Giorgio, Carmelo; Cinieri, Saverio; Latteri, Fiorenza; Sergi, Concetta; Pappagallo, Giovanni L.; Sergio Cordio, Stefano; Salice, Placida; Sambataro, Daniela; Potenza, Enrico
Assessing awareness and knowledge of Human Papilloma virus infection in high school studente
2019-01-01 Carapezza, L.; Fusto, C.; Salice, P.; Commendatore, O.; Russo, A. E.; Sambataro, D.; Longhitano, L.; Martines, C.; Cordio, S.; Bordonaro, R.
Drug-drug interaction between antineoplastic drug based protocols and general medications: a novel approach in the clinical practice
2009-01-01 Tricarico, Domenico; Aieta, M; Bordonaro, R; Calvi, N; Caputo, A; Cetrone, M; Facchini, G; Ficorella, C; Iaffaioli, Rv; Lorusso, V; Pelliccione, M; Sambataro, D; Tartarone, A; Pecori, A.
Examining perceptions of financial toxicity among cancer patients: The Financial Toxicity 16 Questionnaire.
2020-01-01 Bordonaro, Roberto; Castagna, Fabrizio; Piazza, Dario; Sergio Cordio, Stefano; Sergi, Concetta; Emanuela Fassari, Giuseppina; Martines, Concetta; Commendatore, Oriana; Sambataro, Daniela; Carapezza, Luigia; Mattina, Marco; Erika Russo, Alessia; Gebbia, Vittorio
Implementation of a clinical governance model (UFA-ONCO-HEMA model) for anticancer drugs delivering and its adoption by a Regional Health Department
2014-01-01 Fassari, G.; Consoli, U.; Sambataro, D.; Caudullo, D.; Davì, S.; Mattina, M.; Impera, S.; Scaccianoce, I.; Randisi, A.; Murolo, G.; Pitocchi, O.; Buemi, A.; Bordonaro, R.
Pertuzumab, Trastuzumab, Docetaxel: a single istitution clinical exeperience for Her 2 positive metastatic breast cancer (mBC)
2016-01-01 Martines, C.; Lavenia, G.; Salice, P.; Latteri, F.; Commendatore, O.; Sambataro, D.; Burrafato, G.; Mattina, M.; Amadio, P.; Bordonaro, R.
PRELIMINARY DATA OF THE ASSOCIATION OF CIS-PLATINUM, PEMETREXED AND BEVACIZUMAB (CPBEV) AS FIRST-LINE THERAPY FOR LOCALLY ADVANCED OR METASTATIC ADENOCARCINOMA OF THE LUNG
2009-01-01 Bordonaro, Roberto; Soto-Parra, Hector; Pumo, Vitalinda; Nacci, Angelo; Latteri, Fiorenza; Rizzo, Piero; Cordio, Stefano; Sambataro, Daniela; Potenza, Enrico; Cinieri, Saverio
Preliminary study on financial toxicity perception among cancer patients: The financial toxicity questionnaire 16
2020-01-01 Bordonaro, R.; Castagna, F.; Piazza, D.; Cordio, S. S.; Sergi, C.; Fassari, G. E.; Martines, C.; Commendatore, O.; Sambataro, D.; Carapezza, L.; Mattina, M.; Russo, A. E.; Gebbia, V.
Second- and third-line chemotherapy in advanced gastric cancer: a real-life clinical picture.
2014-01-01 Uccello, Mario; Cordio, Stefano; Mattina, Marco; Sambataro, Daniela; Martines, Concetta; Salice, Placida; Centone, D.; Giannone, Giorgio; Bordonaro, Roberto
The clinical governance model (UFA-ONCO-EMA model) for anticancer drugs delivering of the ARNAS Garibaldi: third year experience
2015-01-01 Fassari, G. E.; Bordonaro, R.; Sambataro, D.; Mattina, M.; Impera, S.; Caudullo, D.; Pitocchi, O.; Comandatore, O.; Martines, C.; Buemi, A.; Consoli, U.; Murolo, G.
THE ONCOLOGICAL SITUATION IN SICILY: PUBLIC AND PRIVARE STRUCTURES
2023-01-01 Vitello, S.; Blasi, L.; Bordonaro, R.; Borsellino, N.; Cordio, S.; Di Cristina, L.; Ferrau’, F.; Gebbia, V.; Giannitto, C.; Giuffrida, D.; Sambataro, D.; Silvestris, N.; Soto Parra, H.; Spada, M.; Tralongo, P.; Verderame, F.; Zerilli, F.; Savarino, A.; Carnaghi, C.; Barni, S.
Tromboembolismo in oncologia medica
2008-01-01 Sambataro, D.; Bordonaro, R.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 5-Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) plus Bevacizumab in patients with metastatic colo-rectal cancer (MCRC): a multicentric phase II trial | 1-gen-2009 | Cordio, S; Soto Parra, Hj; Pumo, V; Condorelli, S; Latteri, F.; Sambataro, D; Rosati, G.; Aprile, G; Fassari, G; De Pauli, F; Bordonaro, R | |
| A data collection representative of an outcome analysis in advanced Non Small Cell Lung Cancer (NSCLC) expressing EGFR mutations after failure of first line therapy with Tyrosine Kinase Inhibitors (TKIs) with careful on post progression survival | 1-gen-2016 | Sergi, C.; Commendatore, O.; Burrafato, G.; Martines, C.; Garozzo, S.; Cordio, S.; Sambataro, D.; Cinà, D.; Miraponte, S.; Bordonaro, R. | |
| Activity and safety of CPBev regimen (Cis-platinum, Pemetrexed and Bevacizumab) as first-line therapy for locally advanced or metastatic adenocarcinoma of the lung: final results of a phase II study. | 1-gen-2013 | Bordonaro, Roberto; Soto-Parra, Hector; Sergi, Concetta; Giannitto Giorgio, Carmelo; Cinieri, Saverio; Latteri, Fiorenza; Cordio, Stefano; Salice, Placida; Morales, Concetta; Sambataro, Daniela; Potenza, Enrico | |
| Activity and safety of CPBev regimen (cisplatinum, pemetrexed, and bevacizumab) as first-line therapy for locally advanced or metastatic adenocarcinoma of the lung: Final results of a phase II study. | 1-gen-2012 | Bordonaro, Roberto; Soto-parra, Hector; Giannitto-Giorgio, Carmelo; Cinieri, Saverio; Latteri, Fiorenza; Sergi, Concetta; Pappagallo, Giovanni L.; Sergio Cordio, Stefano; Salice, Placida; Sambataro, Daniela; Potenza, Enrico | |
| Assessing awareness and knowledge of Human Papilloma virus infection in high school studente | 1-gen-2019 | Carapezza, L.; Fusto, C.; Salice, P.; Commendatore, O.; Russo, A. E.; Sambataro, D.; Longhitano, L.; Martines, C.; Cordio, S.; Bordonaro, R. | |
| Drug-drug interaction between antineoplastic drug based protocols and general medications: a novel approach in the clinical practice | 1-gen-2009 | Tricarico, Domenico; Aieta, M; Bordonaro, R; Calvi, N; Caputo, A; Cetrone, M; Facchini, G; Ficorella, C; Iaffaioli, Rv; Lorusso, V; Pelliccione, M; Sambataro, D; Tartarone, A; Pecori, A. | |
| Examining perceptions of financial toxicity among cancer patients: The Financial Toxicity 16 Questionnaire. | 1-gen-2020 | Bordonaro, Roberto; Castagna, Fabrizio; Piazza, Dario; Sergio Cordio, Stefano; Sergi, Concetta; Emanuela Fassari, Giuseppina; Martines, Concetta; Commendatore, Oriana; Sambataro, Daniela; Carapezza, Luigia; Mattina, Marco; Erika Russo, Alessia; Gebbia, Vittorio | |
| Implementation of a clinical governance model (UFA-ONCO-HEMA model) for anticancer drugs delivering and its adoption by a Regional Health Department | 1-gen-2014 | Fassari, G.; Consoli, U.; Sambataro, D.; Caudullo, D.; Davì, S.; Mattina, M.; Impera, S.; Scaccianoce, I.; Randisi, A.; Murolo, G.; Pitocchi, O.; Buemi, A.; Bordonaro, R. | |
| Pertuzumab, Trastuzumab, Docetaxel: a single istitution clinical exeperience for Her 2 positive metastatic breast cancer (mBC) | 1-gen-2016 | Martines, C.; Lavenia, G.; Salice, P.; Latteri, F.; Commendatore, O.; Sambataro, D.; Burrafato, G.; Mattina, M.; Amadio, P.; Bordonaro, R. | |
| PRELIMINARY DATA OF THE ASSOCIATION OF CIS-PLATINUM, PEMETREXED AND BEVACIZUMAB (CPBEV) AS FIRST-LINE THERAPY FOR LOCALLY ADVANCED OR METASTATIC ADENOCARCINOMA OF THE LUNG | 1-gen-2009 | Bordonaro, Roberto; Soto-Parra, Hector; Pumo, Vitalinda; Nacci, Angelo; Latteri, Fiorenza; Rizzo, Piero; Cordio, Stefano; Sambataro, Daniela; Potenza, Enrico; Cinieri, Saverio | |
| Preliminary study on financial toxicity perception among cancer patients: The financial toxicity questionnaire 16 | 1-gen-2020 | Bordonaro, R.; Castagna, F.; Piazza, D.; Cordio, S. S.; Sergi, C.; Fassari, G. E.; Martines, C.; Commendatore, O.; Sambataro, D.; Carapezza, L.; Mattina, M.; Russo, A. E.; Gebbia, V. | |
| Second- and third-line chemotherapy in advanced gastric cancer: a real-life clinical picture. | 1-gen-2014 | Uccello, Mario; Cordio, Stefano; Mattina, Marco; Sambataro, Daniela; Martines, Concetta; Salice, Placida; Centone, D.; Giannone, Giorgio; Bordonaro, Roberto | |
| The clinical governance model (UFA-ONCO-EMA model) for anticancer drugs delivering of the ARNAS Garibaldi: third year experience | 1-gen-2015 | Fassari, G. E.; Bordonaro, R.; Sambataro, D.; Mattina, M.; Impera, S.; Caudullo, D.; Pitocchi, O.; Comandatore, O.; Martines, C.; Buemi, A.; Consoli, U.; Murolo, G. | |
| THE ONCOLOGICAL SITUATION IN SICILY: PUBLIC AND PRIVARE STRUCTURES | 1-gen-2023 | Vitello, S.; Blasi, L.; Bordonaro, R.; Borsellino, N.; Cordio, S.; Di Cristina, L.; Ferrau’, F.; Gebbia, V.; Giannitto, C.; Giuffrida, D.; Sambataro, D.; Silvestris, N.; Soto Parra, H.; Spada, M.; Tralongo, P.; Verderame, F.; Zerilli, F.; Savarino, A.; Carnaghi, C.; Barni, S. | |
| Tromboembolismo in oncologia medica | 1-gen-2008 | Sambataro, D.; Bordonaro, R. |